The efficient control of gene expression in vivo from lentiviral vectors remains technically challenging. To analyze inducible gene expression in a human setting, we generated 'human immune system' (HIS) mice by transplanting newborn BALB/c Rag2 À/À IL-2Rg c À/À immunodeficient mice with human hematopoietic stem cells transduced with a doxycyclineinducible lentiviral vector. We compared several methods of doxycycline delivery to mice, and could accurately measure doxycycline in vivo using a new sensitive detection assay. Two different lentiviral vector designs with constitutive (TRECMV-V14) or autoregulatory (TREAuto-V14) expression of an optimized reverse tetracycline transactivator were used to transduce human hematopoietic stem cells. After transplantation into immunodeficient mice, we analyzed the expression of the green fluorescent protein (GFP) reporter gene in the human hematopoiesis-derived cells that develop and accumulate in the generated HIS mice. We show efficient inducible GFP expression in adult HIS mice containing TREAuto-V14-transduced human cells, whereas GFP expression is poor with the TRECMV-V14 vector. Multiple cycles of doxycycline exposure in the TREAuto-V14 group result in repeated cycles of GFP expression with no loss of intensity. These findings are of major interest for gene therapy and basic research settings that require inducible gene expression.
Introduction
Experimental systems in which gene expression can be modulated 'at will' are important for many areas of basic research and gene therapy. Among the available approaches, the tetracycline (Tc)-inducible gene regulation system has been proven efficient, both in vitro and in vivo.
1,2 The prokaryotic Tc-inducible gene regulation system is based on two elements of the Tn10 Tc resistance operon of Escherichia coli: the repressor protein (TetR) and its target DNA sequence, the tet operator (tetO). 3, 4 In the absence of Tc, TetR dimerizes and binds to tetO, blocking transcription of this operon. When Tc is present, its binding to TetR induces a conformational change in TetR, which dissociates from tetO, alleviating the transcriptional blockade. By modification of four amino acids in TetR, a reverse TetR mutant was developed that requires doxycycline (dox), a potent analog of Tc, to bind to tetO. 5 In mammalian cells, the dox-regulated system is mainly used for the induction of a target gene under transcriptional control of a Tc-responsive element (TRE) promoter that contains tetO-binding sites fused to a DNA sequence, providing basal promoter activity. Creation of tetO-binding transcriptional transactivator (TA) molecules for mammalian systems was facilitated by fusing TetR or reverse TetR mutant to the VP16 activation domain of herpes simplex virus, giving rise to tTA and rtTA, respectively. 5, 6 The tTA protein activates tetO-mediated transcription in the absence of dox (TetOff system), whereas rtTA induces transcription in the presence of dox (Tet-On system). Several features, for example, a high induction capacity and rapid responsiveness, make the Tet-On system particularly attractive as an in vivo inducible system. 1, 7 The in vivo consequences of long-term exposure to antibiotics-such as Tc and dox-also have to be taken into account. Using the Tet-On approach, the extent of exposure to dox is rather limited when expression of the target gene is required only for a short period of time. The induction of gene expression in restricted time frames may be required in some gene therapy settings, for example, to avoid toxicity resulting from the gene product itself.
A successful dox-dependent gene expression strategy relies on two components: the in vivo dox levels and the vector used for gene delivery. Over the past 10 years, improvements in the dox-dependent gene expression system have been obtained. A variety of rtTA proteins have been developed with reduced basal activity, increased induction capacity and increased dox sensitivity. For example, the recently developed variants, rtTA-V14, -V15 and -V16, require only 10 ng ml À1 dox to be as active as the rtTA2 S -S2 variant at 1000 ng ml À1 dox. [8] [9] [10] This difference in dox sensitivity may result in differential gene expression. The determination of dox levels reached in vivo is thus critical for optimal dox-dependent gene activation with a given rtTA and for reduction of the delivered dose of dox. The vector used for delivery of the inducible transgene is also important. Lentiviral vectors were recently developed in which the TRE-regulated transgene as well as the rtTA protein are combined, allowing the transfer of the complete Tet-On system in one single transduction. 11, 12 In these vectors, rtTA can be expressed either from a constitutive promoter or through an autoregulatory loop. The autoregulatory expression of rtTA was shown to be superior in vitro as compared with constitutive expression, resulting in lower basal expression levels, higher viral titers, improved induction kinetics and increased gene expression levels. 11 However, these differences have not yet been analyzed in an in vivo setting, notably in the context of human cells.
Several humanized mouse models have been developed and optimized over the last two decades for the experimental study of human immune system (HIS) development and function. [13] [14] [15] [16] Along with others, we have recently established BALB/c Rag-2 À/À IL-2Rg c À/À newborn mice as a new xenograft model for human hematopoietic stem cell (HSC) transplantation. 17, 18 In contrast with other immunodeficient mouse strains humanized for the immune system (for example, C.B-17 SCID mice or NOD/SCID mice), 14 the resulting HIS (BALB-Rag/g) mice show all major human myeloid and lymphoid cellular compartments, giving access to in vivo and ex vivo experimentation on human immune cells. [14] [15] [16] Dox-dependent gene expression strategies have been applied to humanized NOD/SCID mice, 19 but the more robust human reconstitution obtained in the HIS (BALBRag/g) mice renders this model more attractive for prospective study of gene function in vivo during human hematopoiesis. As previously mentioned, selection of the rtTA variant and the dox delivery method have to be carefully evaluated to obtain optimal gene induction effectiveness in this in vivo Tet-On setting.
In this study we evaluated the dox concentrations reached in the plasma of the HIS (BALB-Rag/g) mice after a series of dox administration/withdrawal, using different routes of dox administration, either in the drinking water or in the diet. Furthermore, we compared the performance of two different lentiviral vectors, expressing rtTA either constitutively (TRECMV-V14) or through an autoregulatory loop (TREAuto-V14), for their capacity to induce gene expression in vivo upon dox administration. The HIS (BALB-Rag/g) mice were transplanted with human HSC-enriched CD34+CD38À cells transduced with dox-inducible lentiviral vectors, allowing direct monitoring of dox diffusion in the mouse organs through green fluorescent protein (GFP) expression. Our results show that the use of the inducible lentiviral vector with an autoregulatory loop ensures a more robust expression of the reporter gene, with no loss of expression after repeated cycles of dox exposure.
Results
Generation of humanized mice with lentivirus-modified hematopoietic stem cells
We have constructed two lentiviral vectors, TRECMV-V14 and TREAuto-V14, deriving from the TRECMVR2 and TREAutoR3 vectors, respectively.
11 These two constructs belong to the third generation of lentiviral selfinactivating vectors, 21, 22 with the central polypurine tract for enhanced transduction efficiency and the hepatitis B virus post-transcriptional regulatory element for enhanced gene expression. 23 In these two vectors, the rtTA2 S -S2 (TRECMVR2) and rtTA3 (TREAutoR3) were replaced by the improved rtTA-V14 variant that shows increased dox sensitivity and contributes to better viral replication in the HIV-rtTA backbone, as compared with rtTA2 S -S2. 10 However, the two elements of the Tet-On system (TRE and rtTA) are combined in a different manner in these vectors. In TRECMV-V14, expression of GFP is under the control of the TRE promoter, consisting of seven copies of tetO fused to the minimal promoter derived from the human CMV immediate early gene 1 promoter, whereas rtTA expression is driven by the constitutive CMV promoter (Figure 1a) . In TREAuto-V14, rtTA is placed in an autoregulatory loop where the TRE promoter expresses a bicistronic mRNA that encodes both GFP and rtTA through an internal ribosomal entry site (Figure 1b) .
The injection of human HSC into immunodeficient (BALB/c RAG2
) newborn mice results in the development of a fully differentiated multilineage human immune system in vivo. Within 8 weeks, all major human lymphoid-and myeloid-cell compartments, including B cells, abT cells, gdT cells, natural killer cells, monocytes/macrophages, and conventional and plasmacytoid dendritic cells, are generated and detected in the lymphoid organs of such HIS (BALB-Rag/g) mice. 14, 17, 18, 29, 31 To compare the dox-dependent gene expression driven by the two different lentiviral vectors in vivo, we transduced human HSC (CD34+CD38À cells) with TRECMV-V14 or TREAuto-V14 vectors before xenograft transplantation (Figure 1c) . The transduced human CD34+CD38À cells were transplanted into immunodeficient mice, and an aliquot was cultured in vitro in the presence of dox for 3.5 days for determining the transduction efficiency. Using flow cytometry determination of GFP expression as a readout, this initial transduction efficiency was compared with the recovery of transduced human cells in the HIS (BALB-Rag/g) mice 8 to 12 weeks after hematopoietic reconstitution, that is, when human cell colonization of the lymphoid organs is optimal (Figure 1c) .
Kinetics of dox accumulation and clearance in the plasma of humanized mice
Optimal induction of the Tet-On system critically depends on the dox sensitivity of the rtTA variant used, and dox delivery has to be calibrated to reach an effective, non-toxic concentration in vivo. We compared Inducible gene delivery in 'human immune system' mice M Centlivre et al several dox delivery procedures with adult (8-12 weeks after transplantation) HIS (BALB-Rag/g) mice, either in the drinking water (1 mg ml À1 ) or the food (2 g kg and 6 g kg À1 dox-diets). Blood was harvested from the animals at several time points to collect serial plasma samples. We determined the dox concentration reached in the HIS (BALB-Rag/g) plasma samples using a new biological assay, referred to as the HeLaDOX assay, that allows dox measurement in small biological samples. 20 In the first set of experiments, HIS (BALB-Rag/g) mice continuously received dox for up to 3 weeks. High plasma dox concentrations (41.000 ng ml
À1
) were obtained in all the HIS (Rag/g) mice, irrespective of the delivery method (Figure 2a) . This high plateau level was reached as early as 3 days after onset of the treatment 
IL-2Rgc
À/À mice are injected intrahepatically with transduced HSCs. The transduction efficiency is evaluated based on GFP expression after 3.5 days in culture in the presence of dox. The HIS (BALB-Rag/g) mice are tested after 8 weeks for the presence of human cells in the blood and further analyzed after onset of dox treatment, starting 8-12 weeks after transplantation. GFP, green fluorescent protein; IRES, internal ribosome entry site; LTR, long terminal repeat; rtTA, reverse Tet transcriptional transactivator; TRE, Tet responsive element.
Inducible gene delivery in 'human immune system' mice M Centlivre et al and was stably maintained for the 3 weeks of dox treatment. The animals on the 6 g kg À1 doxdiet regimen showed the highest plasma dox concentration (8.700 ± 2.300 ng ml
À1
). No obvious signs of animal discomfort were noticed in all experimental groups. We next analyzed the kinetics of dox accumulation and clearance in the plasma of dox-fed HIS (BALB-Rag/g) mice (6 g kg À1 dox-diet) ( Figure 2b ). The dox level measured 2 days after dox withdrawal dropped to the pre-dox value, with a 485% decrease of the dox concentration only 1 day after withdrawal. A second dox-food administration showed rapid on-kinetics, with 50% of the dox level plateau reached after 1 to 2 days and maximal dox concentration after 1 week. Similar results were obtained with dox supplementation in the drinking water (1 mg ml
; data not shown). Overall, our results show that the half-life of dox in the blood is in the range of 1 day, allowing quick on/off dox cycles, independently of the route of administration.
Doxycycline is a member of the tetracycline family with a high capacity of diffusion through the blood-brain barrier. 32 The dox-inducible system is thus commonly used for gene expression studies in the brain, but the dox level that can be obtained in situ has never carefully been addressed. We therefore harvested the CSF of the HIS (BALB-Rag/g) mice that received dox for 3 weeks in drinking water (1 mg ml À1 ) or food (2 g kg À1 and 6 g kg À1 dox-diet), and we determined the dox concentration ( Figure 2c ). In parallel, we measured the plasma dox concentration at the time of CSF harvest ( Figure 2d ). The CSF dox concentrations in the HIS (BALB-Rag/g) mice were approximately 30-fold lower than the corresponding plasma levels. With 6 g kg À1 doxdiet, we measured on average 400 ng ml À1 dox in the CSF, and this value dropped threefold for the 2 g kg À1 dox-diet. Such values are compatible with the use of the more sensitive rtTA variants for gene induction in the brain. With dox-drinking water, we were unable to detect dox in the CSF above the background level measured in non-treated animals. Our results highlight that high dose of dox-delivery in food is highly desirable for proper gene induction in the brain.
GFP induction in human cells in the blood of HIS mice
We followed the kinetics of GFP expression when dox was added and subsequently withdrawn from the water (1 mg ml
À1
) and food regimen (6 g kg À1 dox-diet) of HIS (BALB-Rag/g) mice. We compared the in vivo capacity of dox-induced GFP expression between TRECMV-V14 and TREAuto-V14 lentiviral vectors. Similar transduction efficiencies were scored for the two vectors (Figure 3a ). In the adult HIS (BALB-Rag/g) mice (8-12 weeks after transplantation), the GFP expression by human CD45+ blood cells was close to undetectable in the absence of dox for both vectors, whereas dox treatment induced GFP expression in a fraction of human CD45+ blood cells (Figure 3b ). When compared with the original transduction efficiency, the extent of GFP induction by dox was largely lost for the TRECMV-V14 but not for the TREAuto-V14 (Figure 3b ).
To stipulate the in vivo durability of dox-inducible GFP expression, we calculated the ratio of the in vivo (GFP induction in CD45+ cells of HIS mice) and in vitro (initial transduction efficiency) percentage of GFP+ cells over time. The recovery of GFP expression after dox treatment of the animals was only 10-15% of the initial transduction efficiency with the TRECMV-V14 (Figure 3c ), whereas almost 100% of GFP expression recovery was observed with the TREAuto-V14-transduced human Figure 2 Determination of dox level reached in the HIS (BALB-Rag/g mice during dox delivery/withdrawal cycle. The dox levels were determined in the plasma of HIS (BALB-Rag/g) mice before (pre-dox) and during dox treatment. (a) The HIS (BALB-Rag/g) mice received dox for a maximum of 3 weeks, either in the water (1 mg ml À1 ; crosses, n ¼ 14-22 depending on the time point) or in the food (2 g kg
The dox levels in the plasma of dox-fed HIS (BALB-Rag/g) mice (6 g kg À1 dox-diet) were determined during rounds of dox administration (closed triangles, n ¼ 17-33 in first round, n ¼ 3-6 in the second round) and dox withdrawal (open triangle, n ¼ 4-10). The dox levels were also determined in the CSF (c) and the plasma (d) of the same HIS (BALB-Rag/g) mice that either received no dox (open diamonds, n ¼ 5), dox in the water (1 mg ml
dox-diet, closed triangles, n ¼ 7) for 3 weeks. The results are pooled from two to four independent experiments, and each dot represents one individual animal.
Inducible gene delivery in 'human immune system' mice M Centlivre et al cells (Figure 3d ). The results from HIS (BALB-Rag/g) mice receiving dox in drinking water (1 mg ml
) or diet (6 g kg À1 ) were pooled, as no differences in GFP expression (frequency of GFP+ cells; mean fluorescence intensity) were observed between the two delivery methods (not shown). The expression of GFP reached a plateau value as early as day 3 after onset of dox treatment with both vectors. For TREAuto-V14, a reduction in the percentage of GFP+ cells was observed between 1.5 and 3 weeks of dox treatment. Upon withdrawal of dox, the frequency of human GFP+ cells decreased to pre-dox value in a slow manner, with the GFP expression still being detectable at 3 days off-dox with both vectors (Figures 3c and d) . Considering that both vectors express a destabilized GFP (half-life of 2 h), 33 the slow disappearance of GFP was likely due to the high dox-sensitivity of rtTA-V14. Overall, the mean fluorescence intensity of GFP after 3 days of dox ) were pooled, as no differences in GFP expression (frequency of GFP+ cells; MFI) were observed between the two delivery methods. *Po0.05; **Po0.01.
Inducible gene delivery in 'human immune system' mice M Centlivre et al delivery was significantly higher when expression was driven by the TREAuto-V14 vector (fluorescence intensity ± 110-fold the background value), as compared with the TRECMV-V14 vector (±65-fold), but this difference was not maintained after 1.5 week or 3 weeks of treatment (Figure 3e ).
Induction of GFP expression in lymphoid organs and human immune cell subsets
We next evaluated the diffusion of dox in the HIS (BALB-Rag/g) mice organs, using GFP expression as a read-out. The animals were analyzed after 3 weeks of dox treatment for the frequency of GFP+ cells among human ( (Figure 4a ). In the spleen, no human GFP+ cells were observed in the absence of dox treatment for both vectors (Figure 4b ). In the presence of dox, human GFP+ cells accumulated with both lentiviral vectors. In accordance with our observations in blood, the recovery of GFP expression was significantly lower for TRECMV-V14 as compared with TREAuto-V14 (Figure 4b ). All human immune cell subsets expressed GFP, although the frequency of GFP+ cells was higher in B cell and conventional dendritic cell subsets for both vectors (Figures 4a and c) . The GFP mean fluorescence intensity was lower in GFP+ B cells (±65-fold the background value) and T cells ( ± 45-fold), as compared with plasmacytoid-and conventional-dendritic cells subsets ( ± 100-fold) (not shown). Identical results were obtained in the bone marrow, the thymus and the liver of the analyzed HIS (BALB-Rag/g) mice (Figures 4d-f and not shown). Induction of GFP expression in TREAuto-V14 transduced human cells was significantly (Po0.05) lower in the thymus (around 40% recovery) than spleen, bone marrow and liver (65-80% recovery). It should be noted that the human reconstitution in the brain of HIS (BALBRag/g) is virtually absent, and we were consequently unable to evaluate the extent of GFP induction in this location.
GFP expression after several on/off cycles of dox delivery
One desirable feature of an inducible vector is the ability to support repeated induction cycles of gene expression. We therefore monitored the recovery of human GFP+ cells after multiple on/off cycles. The mice that had received dox diet for 3 weeks were subsequently given food without dox for 1.5 week (1.5 week off), with dox for 1 week (1 week on), without dox for 1.5 week (1.5 week off) and finally with dox for 1 week (1 week on). Because the TRECMV-V14-transduced cells behaved poorly, we focused on the HIS (BALB-Rag/g) mice generated with TREAuto-V14-transduced human HSC to ensure optimal measurement of GFP induction. We measured the frequency of human GFP+ cells in the blood. We observed that GFP expression was induced to nearly 100% of the pre-engraftment level, and subsequently switched-off during dox withdrawal. This pattern could be repeated in subsequent cycles of dox delivery (Figure 5a) . Importantly, the GFP recovery after each cycle of dox delivery was maintained to a similar level of at least 70% and strict on/off control of transgene expression was preserved. A similar level of GFP mean fluorescence intensity was also obtained after each cycle of dox delivery (Figure 5b ). We also assessed GFP expression in multiple organs after the first and the last cycles of dox treatment. Bone marrow, thymus, spleen and liver of the mice were harvested and screened for GFP expression by the CD45+ human hematopoiesisderived cells (Figures 5c-f) . As observed in the blood, GFP expression was still efficiently induced after the third dox delivery, and recovery of human GFP+ cells was similar between the first and the third cycles. As before, the lowest overall induction level was observed for thymus-derived cells.
Discussion
In this study we analyzed the parameters that are critical for successful transgene control in vivo in a human context, using the widely used Tet-On system. The proof of concept for inducible gene delivery in a humanized mouse system was performed by transplanting engineered human HSC-enriched CD34+CD38À cells into NOD/SCID immunodeficient mice, 19 but residual mouse T-cell development, B-cell development and natural killer cell activity in this genetic background intrinsically limit the extent of human reconstitution.
14 To circumvent this potential limitation, we have reconstituted immunodeficient BALB/c Rag2 
IL-2Rg c
À/À mice are fully defective for T-, B-and natural killer cell development and consequently show an improved susceptibility to xenograft transplantation.
14 All major lineages of the HIS are generated in the resulting HIS (BALB-Rag/g) mice, giving access to a prospective in vivo study of Tet-On approaches in the human hematopoietic system. We tested different methods of dox delivery, the dox levels obtained in plasma and CSF, different lentiviral vector designs, and the induction of transgene expression in different tissues and immune cell subsets.
Optimal induction of gene expression in vivo depends on the dox level reached in situ, in relationship with the dox sensitivity of the rtTA used in the transduced vector. There are obvious in vivo technical constrains that are easily circumvented in vitro, such as fine manipulation of dox concentration and very rapid supplementation or withdrawal of dox. The in vivo situation is more complex, due to, for instance, the differential dox penetration into various organs and cellular compartments, or the kinetics of dox accumulation and clearance. We compared two non-invasive approaches of delivering dox to the humanized mice: in drinking water (1 mg dox per ml of water, that is, 1 g kg À1 of water) or the food (2 g kg À1 or 6 g kg À1 diet). Considering that the daily intake of water and food by normal adult mice is B5 g of water (that is, B5 ml) and B4 g food, 34 exposure to dox is expected to follow the hierarchy of 6 g kg À1 food 42 g kg À1 food 4 water 1 mg ml
À1
. This is what we observed when we measured plasma dox levels ( Figure 2) . The dox concentration reached in all treated animals was above the level required for rtTA activation, Inducible gene delivery in 'human immune system' mice M Centlivre et al both for the highly dox-sensitive rtTA-V14 10 and the rtTA2 S -M2 and rtTA2 S -S2 variants. 8 It should be noted that dox delivery in drinking water imposes several technical limitations, as well as side effects. For instance, the bitter taste of dox in water-as well as sucrose addition to mask it-influences the daily water intake and limits the maximal concentration of dox. 34 Signs of mouse discomfort-such as weight loss and dehydration-may be observed after only 2 days of dox treatment. 35 Furthermore, dox is known to be light sensitive and relatively instable in water, and it is advised to change the supply every other day. d-f) The graphs show the recovery of GFP expression in total human cells of the bone marrow (d), the thymus (e) and the liver (f), as before. Data were generated and pooled from two (TREAuto-V14) to four (TRECMV-V14) independent HSC transductions, and each dot in the graphs represents one individual animal. Results from HIS (BALB-Rag/g) mice receiving dox in drinking water (1 mg ml À1 ) or diet (6 g kg
) were pooled, as no differences in GFP expression were observed between the two delivery methods.
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In comparison, the dox-food delivery presents several advantages, for example, protection from light, improved dox stability and less frequent supply replacements (once a week). Most importantly, higher dox concentrations can be delivered in the food without any signs of animal discomfort, which allows reaching high dox levels in organs showing restricted diffusion of the antibiotic. For instance, we found in the brain only B3% of the corresponding plasma dox concentration (Figures 2c and d) . The delivery of high levels of dox in the food (for example, 6 g kg
) therefore ensures optimal CSF dox levels (400 ng ml À1 on average) for proper function of the improved Tet-On systems. 10 To determine the efficiency of dox-regulated lentiviral vectors, we generated HIS (BALB-Rag/g) mice with transduced human CD34+CD38À cells for inducible GFP expression. We compared two dox-sensitive lentiviral vectors expressing rtTA-V14 either constitutively or in an autoregulatory loop manner. The two vectors showed a similar ex vivo transduction efficiency on human CD34+CD38À cells, as determined by GFP expression after 3.5 days of culture in the presence of saturating dox concentration. In contrast, only the use of the autoregulatory loop ensures a robust expression of the reporter gene in HIS (BALB-Rag/g) mice, in all the lymphoid organs and human immune cell subsets analyzed (Figures 3 and 4) . As the two vectors make use of the same rtTA-V14 variant, Tet-responsive element and destabilized GFP 33 (half-life o2 h), we can exclude a differential effect of dox saturating levels on the Tet-On Figure 5 Multiple in vivo cycles of induction of GFP expression with TREAuto-V14. (a) The kinetics of GFP expression were followed in the blood of the human immune system (HIS; BALB-Rag/g) mice generated with TREAuto-V14-transduced human hematopoietic stem cells (HSCs). Three rounds of dox administration in diet (2 g kg À1 ; closed squares) and dox withdrawal (gray circles) were studied. (b) The GFP mean fluorescence intensity (MFI) of the hCD45+GFP+ population was measured (mean ± s.e.m.) after the first (ON-1, 3 weeks, n ¼ 17), the second (ON-2, 1 week, n ¼ 10) and the third (ON-3, 1 week, n ¼ 9) round of dox delivery. The results are expressed as indicated in the legend of Figure 3e. (c-f) The ratio between the in vivo GFP induction and the HSC transduction efficiency was determined in the TREAuto-V14 groups of mice before dox treatment (n ¼ 4), after the first (ON-1; n ¼ 18) and the third round (ON-3; n ¼ 9) of dox delivery in the bone marrow (c), the thymus (d), the spleen (e) and the liver (f) of the treated mice. Data were generated and pooled from two (TREAuto-V14) independent HSC transductions, and each dot represents one individual animal.
Inducible gene delivery in 'human immune system' mice M Centlivre et al axis. Importantly, we previously observed that the autoregulatory loop vector also outperforms the regular vector with respect to the basal expression level without dox. 11 It is likely that limited GFP expression can be driven in the absence of dox by rtTA, which is continuously produced from the CMV promoter in the TRECMV-V14 vector configuration (Figure 3b) .
Future work specifically addressing the poor performance of the TRECMV-V14 vector in vivo will be necessary to better understand the underlying mechanisms accounting for this phenomenon. Still, we can speculate on the marked difference in durable GFP expression between the two vectors. Constitutive expression of rtTA by the TRECMV-V14 vector may lead to cellular accumulation of rtTA, which may disturb cellular metabolism and cause cellular toxicity. This could be achieved either through a short-term process leading to a rapid loss of the transduced cells, or as a long-term consequence of reduced proliferation capacity of the transduced cells resulting in growth advantage for the non-transduced cells. These hypotheses are in accordance with previous data showing in vitro cytotoxicity of constitutive rtTA expression in cells transduced with a lentiviral vector, both in the absence or in the presence of dox. 11 Furthermore, the constitutive expression of rtTA results in the loss of transduced cells following repeated induction cycles. 11 In contrast, no loss of transduced cells was noticed in HIS (BALB-Rag/g) mice produced using TREAuto-V14-transduced human CD34+CD38À cells, because dox supplementation resulted in GFP expression to a similar level than the initial transduction efficiency. However, prolonged dox exposure might still result in a deleterious effect for TREAuto-V14-transduced cells, as a reduced frequency of GFP+ cells was observed between 1.5 and 3 weeks of dox treatment (Figure 3d) . Still, multiple, short (o2 weeks) rounds of dox deliver/withdrawal induced GFP expression in HIS (BALB-Rag/g) mice generated using TREAuto-V14-transduced human CD34+CD38À cells with no loss of GFP recovery or GFP intensity ( Figure 5 ). Alternatively, there is strong evidence supporting the notion that CMV promoter driven expression in vivo is not predictable 37 and it cannot be excluded that CMV promoter silencing occurs in the human cells transduced with the TRECMV-V14 vector, for example, through DNA methylation and histone deacetylation. 38, 39 Finally, it is unlikely that an immune response against rtTA-expressing cells is taking place in the HIS (BALB-Rag/g) mice that we used in this study. Our animals are produced from immunodeficient newborn mice, which are reconstituted with immature progenitors of the human hematopoietic system expressing the rtTA protein-at low or high level depending on the vector used. Because the human HSCs differentiate in vivo from this early stage, the human immune system in HIS (BALB-Rag/g) mice is educated in the presence of rtTA and probably sees rtTA as a self-antigen, inducing T-cell tolerance as soon as the first human mature T cells arise. 40 Several perspectives can be envisioned from our results. We have shown that accurate dox-level determination is possible in an in vivo context, which allows testing of several applications based on Tet-On systems with variable dox sensitivity. Our results also indicate that HIS (BALB-Rag/g) mice represent an opportunity to test inducible gene therapy approaches of the hematopoietic system, for instance, as a preclinical tool to test efficacy and safety issues. 28 Inducible gene expression systems are of major fundamental interest in evaluating the role of specific gene products during hematopoiesis in humanized mouse models in a time frame-restricted manner, for example, avoiding potential deleterious effects that could occur during early stages of immune system development. It was previously described that gene expression can be induced multiple times in mouse hematopoiesis-derived cells without gradual loss of expression over time, using an 'all-in-one' lentiviral vector in which rtTA2 S -M2 expression is driven by the phosphoglycerate kinase promoter. 12 We show here with the TREAuto-V14 vector that multiple rounds of gene expression can be induced in human hematopoiesisderived cells in vivo. This is a highly desirable feature in some gene therapy settings, especially when toxicity induced by overexpression or long-term exposure to the gene product has to be avoided, for example, in the treatment of retinal diseases. 41 Recently, such a 'all-inone' lentiviral vector has also been used for proof-ofconcept studies with a therapeutic gene (human clotting factor IX) expressed under the control of a Tet-off regulated system, using direct in vivo delivery of the lentiviral vector. 42 Similar to our results, this study shows long-term maintenance of strictly dox-dependent gene expression, which can be repeatedly turned on and off. The Tet-Off/Tet-On lentiviral vector approach can also be used for inducible knockdown of gene expression in vivo, by expressing short hairpin RNA under the control of an inducible promoter, as shown in rats with inducible ablation of the insulin-receptor expression. 43 Finally, the study of human-specific pathogenesis can also take advantage of conditional-live pathogens, in which replication is depending on the Tet-On gene regulation system. Recently, we have generated a conditional-live HIV-1 variant in which life cycle is dependent on the Tet-On gene regulation system (HIVrtTA). 44, 45 The modifications introduced in the HIV-rtTA genome changed the viral replication control from a constitutive autoregulatory loop driven by the Tat-TAR axis into an inducible autoregulatory loop regulated by dox. In the presence of dox, rtTA can bind to tetO and activate transcription from the downstream transcription initiation site. Transcription and replication of HIV-rtTA are thus critically dependent on dox. 46 Because the major targets of HIV pathogenesis are found in the human immune system, the HIS (BALB-Rag/g) mouse model is extremely suitable to evaluate the in vivo replication and genetic stability of HIV-rtTA, as well as a tool to address new HIV vaccine strategies.
Materials and methods

Plasmid construction
For production of TRECMV-V14 and TREAuto-V14, the rtTA2 S -S2 in TRECMVR2 11 and the rtTA3 in TREAutoR3 11 were replaced with the improved rtTA variant rtTA-V14 (V9I F67S F86Y G138D A209T). 10 The PstI-SpeI fragments of TRECMVR2 and TREAutoR3, respectively, containing the cytomegalovirus (CMV) promoter and the rtTA gene or the internal ribosomal entry site and the rtTA gene, were ligated into a PstI-and SpeI-digested Inducible gene delivery in 'human immune system' mice M Centlivre et al pBluescript SK+ plasmid. The resulting plasmids were used as shuttle plasmids for the cloning of rtTA-V14. The pCMV-rtTA-V14 10 was digested with XcmI and XmaI and the corresponding fragment was ligated into the XcmIand XmaI-digested shuttle plasmids, resulting in rtTA-V14-shuttle plasmids. The rtTA-V14-shuttle plasmids were digested by PstI and SpeI and the corresponding fragments were ligated into TRECMVR2 and TREAutoR3, resulting in the TRECMV-V14 and the TREAuto-V14 lentiviral vectors.
Cell culture
The human embryonic kidney 293T cells and HeLaDOX cells 20 were grown at 37 1C and in 5% CO 2 in Dulbecco's modified Eagle's medium (Gibco BRL), and the SupT1 cells were grown in RPMI 1640 (Gibco BRL, Breda, The Netherlands). Both culture media were supplemented using 10% fetal calf serum, minimal essential medium, nonessential amino acids, penicillin (100 U ml
À1
) and streptomycin (100 mg ml
).
Lentiviral vector preparation and virus titer determination
Lentiviral vectors 21, 22 were produced by co-transfection of vector constructs and packaging constructs pMDLg/ pRRE, RSV-rev and pVSVg in 293T cells with lipofectamine-2000 (Invitrogen, Carlsbad, CA, USA), as previously described. 23, 24 The virus stocks were concentrated using Amicon Ultra concentrator, MWCO 100 000 (Millipore Corporation, Bedford, MA, USA), and aliquots of 0.4 mL were stored at À80 1C. Virus production was determined by CA-p24 enzyme-linked immunosorbent assay. 25 Virus titers were determined by serial dilution of virus on SupT1 cells that were transduced for 6 h. Doxycycline (1000 ng ml
À1
) was added to the cells for 72 h, cells were subsequently harvested and GFP expression was measured using flow cytometry.
Generation of human immune system (HIS; BALB-Rag/g) mice and lentiviral transductions 26 were bred and maintained in isolators, and were fed autoclaved food and water. Human fetal liver was obtained from elective abortions, with gestational age ranging from 14 to 18 weeks. The use of this tissue was approved by the medical ethical committee of the AMC-UvA and was contingent on informed consent. Mice with HIS (BALBRag/g) were generated with minor modifications as compared with previous reports. 17, 18, 27 In brief, magnetically enriched human CD34+ fetal liver cells (498% pure; indirect CD34 human progenitor cell isolation kit, Miltenyi Biotech, Bergisch Gladbach, Germany) were further purified by sorting the HSC-enriched CD34+CD38À cell fraction, using an ARIA sorter (BD Bioscience, Franklin Lakes NJ, USA). The newborn (o1-week old) Rag2 À/À
IL-2Rgc
À/À mice received sublethal (3.5 Gy) total-body irradiation with a 137 Cs source, and were injected intrahepatically with 5-10 Â 10 5 sorted HSC. All manipulations of HIS (BALB-Rag/g) mice were performed under laminar flow.
Human CD34+CD38À cells were transduced with TRECMV-V14 or TREAuto-V14 lentiviral vector before intrahepatic inoculation, as previously described. 28, 29 In brief, the sorted CD34+CD38À cells were cultured overnight in Iscove's modified Dulbecco's medium (Invitrogen, Carlsbad CA, USA) supplemented with Yssel's medium, 30 5% normal human serum and 20 ng ml À1 human stem cell factor, 20 ng ml À1 human thrombopoietin and 20 ng ml À1 human interleukin-7 (all from PeproTech, Rocky Hill, NJ, USA). In the following day, cells were incubated for 6-8 h with virus supernatant in fibronectin-coated plates (30 mg ml
À1
; Takara Biomedicals, Otsu, Shiga, Japan). The cell bulk was next inoculated into the newborn recipients.
Administration and measurement of doxycycline
To induce TRE-dependent gene expression, dox was administrated to the HIS (BALB-Rag/g) mice (8-to 12-week old) using different routes, either in the drinking water or in the food diet. In the drinking water, dox was administered at a concentration of 1 mg ml À1 , supplemented with 1% (wt:vol) sucrose to mask the bitter taste of dox. The dox water was kept in aluminumwrapped bottles to prevent light-induced degradation and was replaced every 2-3 days. Alternatively, the animals were fed dox-food (2 g kg À1 or 6 g kg
À1
, Bioserv, Frenchtown, Canada), which was refreshed once a week.
The dox level in plasma and cerebrospinal fluid (CSF) was determined as previously described. 20 In brief, HeLaDOX cells were plated at a density of 10 4 cells per well in a 96-well plate in a total volume of 180 ml. After 24 h, 20 ml of diluted plasma or CSF samples was added to the cells. As a standard, cells were treated with 20 ml culture medium containing 0-100 ng ml À1 dox. After 48 h, cells were washed with phosphate buffered saline and lysed in passive lysis buffer (Promega, Leiden, The Netherlands). Firefly luciferase activity was determined using luciferase reporter assay according to the manufacturer's protocol (Promega). The dox concentration in the experimental samples was determined by extrapolation from the standard curve established in parallel.
Flow cytometry analysis for cell surface markers
Cell suspensions of the HIS (BALB-Rag/g) mouse organs were prepared in RPMI medium supplemented with 2% fetal calf serum. Cell suspensions were labeled with antihuman mAb targeting the following cell surface markers: CD45 (2D1), CD3 (SK7), CD19 (SJ25C1), HLA-DR (G46-6) from BD Biosciences, and BDCA2 (AC144) from Miltenyi Biotech, to stain, respectively, for all human cells, T cells, B cell, professional antigen-presenting cells and plasmacytoid dendritic cells. All washings and reagent dilutions were carried out with phosphate buffered saline containing 2% fetal calf serum and 0.02% sodium azide. All data acquisitions were performed using LSR-II (BD Bioscience) flow cytometer interfaced to FACS-Diva software system. Cellular debris and dead cells were excluded by their lightscattering characteristics and on the basis of incorporation of 4 0 ,6-diamidino-2-phenylindole (Sigma, Zwijndrecht, The Netherlands).
Statistical analyses
Data were subjected to two-tail paired or unpaired Student's t-test analysis where indicated in the figure legends. The obtained P-values were considered significant when Po0.05.
